Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Anaesthesiology and Intensive Care, Lund, Getingevägen, Lund, Sweden.
Clinical Trial Consultants, Uppsala, Dag Hammarskjölds Väg, Uppsala, Sweden.
PLoS One. 2019 Aug 1;14(8):e0220444. doi: 10.1371/journal.pone.0220444. eCollection 2019.
Endotoxin induces an inflammatory response, with secondary release of cytokines, which can progress to shock and multiple organ failure. We explored whether continuous renal replacement therapy (CRRT) using a modified membrane (oXiris) capable of adsorption could reduce endotoxin and cytokine levels in septic patients.
Sixteen patients requiring CRRT for septic shock-associated acute renal failure and who had endotoxin levels >0.03 EU/ml were prospectively randomized in a crossover double-blind design to receive CRRT with an oXiris filter or with a standard filter. Endotoxin and cytokine levels were measured at baseline and 1, 3, 8, 16 and 24 hours after the start of CRRT. Norepinephrine infusion rate and blood lactate levels were monitored.
During the first filter treatment period, endotoxin levels decreased in 7 of 9 (77.8%) oXiris filter patients, but in only 1 of 6 (16.7%) standard filter patients (P = 0.02). Levels of tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-8 and interferon (IFN)γ decreased more with the oXiris filter than with the standard filter. Lactate concentration decreased with oXiris (-1.3[-2.2 to -1.1] mmol/l, P = 0.02), but not with the standard filter (+0.15[-0.95 to 0.6]). The norepinephrine infusion rate was reduced during oXiris CRRT, but not during standard filter CRRT. In the second filter treatment period, there was no significant reduction in endotoxin or cytokine levels in either group.
CRRT with the oXiris filter seemed to allow effective removal of endotoxin and TNF-α, IL-6, IL-8 and IFNγ in patients with septic shock-associated acute renal failure. This may be associated with beneficial hemodynamic effects.
内毒素会引发炎症反应,继而释放细胞因子,可能发展为休克和多器官衰竭。我们探讨了使用一种改良的吸附膜(oXiris)进行连续肾脏替代治疗(CRRT)是否可以降低脓毒症患者的内毒素和细胞因子水平。
16 名需要接受 CRRT 治疗的脓毒性休克相关急性肾衰竭患者,其内毒素水平>0.03 EU/ml,前瞻性随机分为 oXiris 过滤器组和标准过滤器组,采用交叉双盲设计。在开始 CRRT 后 1、3、8、16 和 24 小时测量内毒素和细胞因子水平。监测去甲肾上腺素输注率和血乳酸水平。
在第一个过滤器治疗期间,9 名(77.8%)oXiris 过滤器患者的内毒素水平下降,而 6 名(16.7%)标准过滤器患者中只有 1 名(16.7%)下降(P = 0.02)。与标准过滤器相比,oXiris 过滤器组肿瘤坏死因子(TNF)-α、白细胞介素(IL)-6、IL-8 和干扰素(IFN)γ水平下降更多。oXiris 组乳酸浓度下降(-1.3[-2.2 至-1.1]mmol/l,P = 0.02),而标准过滤器组没有(+0.15[-0.95 至 0.6]mmol/l)。oXiris CRRT 期间去甲肾上腺素输注率降低,但标准过滤器 CRRT 期间没有降低。在第二个过滤器治疗期间,两组的内毒素和细胞因子水平均无显著降低。
在脓毒性休克相关急性肾衰竭患者中,oXiris 过滤器的 CRRT 似乎可以有效去除内毒素和 TNF-α、IL-6、IL-8 和 IFNγ。这可能与有益的血液动力学效应有关。